Belgravia Hartford Capital Inc. (BLGV.CN)
| Previous Close | 0.0350 |
| Open | 0.0250 |
| Bid | 0.0250 x 0 |
| Ask | 0.0350 x 0 |
| Day's Range | 0.0250 - 0.0250 |
| 52 Week Range | 0.0250 - 0.1300 |
| Volume | |
| Avg. Volume | 23,346 |
| Market Cap | 1.158M |
| Beta (5Y Monthly) | 2.70 |
| PE Ratio (TTM) | 0.16 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
BELGRAVIA HARTFORD Announces Default Judgment Against R&D Pharma
Toronto, Ontario--(Newsfile Corp. - March 7, 2023) - BELGRAVIA HARTFORD CAPITAL INC. (CSE: BLGV) ("Belgravia Hartford", "Belgravia" or the "Company") is pleased to announce that on December 7, 2022, the Ontario Superior Court of Justice entered a Default Judgment against R&D Pharma Corp. ("R&D Pharma") in the case entitled Belgravia Capital International Inc. v. R&D Pharma Corp. (the "Parties"). Belgravia received the Judgment on February 1, 2023. The defendant, R&D Pharma, is ordered to ...
- Newsfile
BELGRAVIA HARTFORD Provides Update on Zonetail Debt and Litigation
Toronto, Ontario--(Newsfile Corp. - January 13, 2023) - BELGRAVIA HARTFORD CAPITAL INC. (CSE: BLGV) ("Belgravia Hartford", "Belgravia" or the "Company") provides an update on the debt owed by Zonetail Inc. (TSXV: ZONE) ("Zonetail") and its litigation with Zonetail. Zonetail Debt Payment of the debt owed to Belgravia by Zonetail under the promissory note (the "Debt") in the current amount of approx. $506,125 including interest at 18%, continues to remain outstanding. Zonetail paid an interest pay
- Newsfile
BELGRAVIA HARTFORD Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - January 12, 2023) - BELGRAVIA HARTFORD CAPITAL INC. (CSE: BLGV) ("Belgravia Hartford", "Belgravia" or the "Company") is pleased to provide a corporate update on the Company.Normal Course Issuer Bid ("NCIB")The Company also announces has purchased through its NCIB for cancellation, a total of 100,000 common shares ("Common Shares") at an average price of $0.04 per share. As of December 31, 2022, the Company has purchased for cancellation approximately 35.98% of
